288 related articles for article (PubMed ID: 21791651)
41. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery.
Boer K; Nellen JF; Patel D; Timmermans S; Tempelman C; Wibaut M; Sluman MA; van der Ende ME; Godfried MH
BJOG; 2007 Feb; 114(2):148-55. PubMed ID: 17305888
[TBL] [Abstract][Full Text] [Related]
42. Maternal antiretrovirals and hepatic enzyme, hematologic abnormalities among human immunodeficiency virus type 1-uninfected infants: the NISDI perinatal study.
Mussi-Pinhata MM; Rego MA; Freimanis L; Kakehasi FM; Machado DM; Cardoso EM; Read JS;
Pediatr Infect Dis J; 2007 Nov; 26(11):1032-7. PubMed ID: 17984811
[TBL] [Abstract][Full Text] [Related]
43. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
[TBL] [Abstract][Full Text] [Related]
44. Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception.
European Collaborative Study
Antivir Ther; 2010; 15(1):41-9. PubMed ID: 20167990
[TBL] [Abstract][Full Text] [Related]
45. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
Bae WH; Wester C; Smeaton LM; Shapiro RL; Lockman S; Onyait K; Thior I; Essex M
AIDS; 2008 Aug; 22(13):1633-40. PubMed ID: 18670224
[TBL] [Abstract][Full Text] [Related]
46. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?
Cotter AM; Garcia AG; Duthely ML; Luke B; O'Sullivan MJ
J Infect Dis; 2006 May; 193(9):1195-201. PubMed ID: 16586354
[TBL] [Abstract][Full Text] [Related]
47. Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe.
Townsend C; Schulte J; Thorne C; Dominguez KI; Tookey PA; Cortina-Borja M; Peckham CS; Bohannon B; Newell ML;
BJOG; 2010 Oct; 117(11):1399-410. PubMed ID: 20716250
[TBL] [Abstract][Full Text] [Related]
48. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
Kesho Bora Study Group
Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845
[TBL] [Abstract][Full Text] [Related]
49. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
[TBL] [Abstract][Full Text] [Related]
50. PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.
Chagomerana MB; Miller WC; Pence BW; Hosseinipour MC; Hoffman IF; Flick RJ; Tweya H; Mumba S; Chimbwandira F; Powers KA
J Acquir Immune Defic Syndr; 2017 Apr; 74(4):367-374. PubMed ID: 27875363
[TBL] [Abstract][Full Text] [Related]
51. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.
Cooper ER; Charurat M; Mofenson L; Hanson IC; Pitt J; Diaz C; Hayani K; Handelsman E; Smeriglio V; Hoff R; Blattner W;
J Acquir Immune Defic Syndr; 2002 Apr; 29(5):484-94. PubMed ID: 11981365
[TBL] [Abstract][Full Text] [Related]
52. Mother-to-child transmission of human immunodeficiency virus in aten years period.
Delicio AM; Milanez H; Amaral E; Morais SS; Lajos GJ; e Silva JL; Cecatti JG
Reprod Health; 2011 Nov; 8():35. PubMed ID: 22129112
[TBL] [Abstract][Full Text] [Related]
53. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Brocklehurst P; Volmink J
Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
[TBL] [Abstract][Full Text] [Related]
54. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.
Machado ES; Hofer CB; Costa TT; Nogueira SA; Oliveira RH; Abreu TF; Evangelista LA; Farias IF; Mercadante RT; Garcia MF; Neves RC; Costa VM; Lambert JS
Sex Transm Infect; 2009 Apr; 85(2):82-7. PubMed ID: 18987014
[TBL] [Abstract][Full Text] [Related]
55. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
[TBL] [Abstract][Full Text] [Related]
56. Impact of Protease Inhibitor-Based Highly Active Antiretroviral Therapy on Fetal Subcutaneous Fat Tissue in HIV-Pregnant Women in a Middle-Income Country.
Borboa-Olivares H; Estrada-Gutierrez G; Martinez-Portilla RJ; Espino-Y-Sosa S; Flores-Pliego A; Espejel-Nuñez A; Camacho-Arroyo I; Solis-Paredes JM; Villafan-Bernal JR; Torres-Torres J
Viruses; 2023 Dec; 16(1):. PubMed ID: 38275945
[TBL] [Abstract][Full Text] [Related]
57. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
Feiterna-Sperling C; Weizsaecker K; Bührer C; Casteleyn S; Loui A; Schmitz T; Wahn V; Obladen M
J Acquir Immune Defic Syndr; 2007 May; 45(1):43-51. PubMed ID: 17356471
[TBL] [Abstract][Full Text] [Related]
58. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Brocklehurst P; Volmink J
Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
[TBL] [Abstract][Full Text] [Related]
59. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.
Frederick T; Homans J; Spencer L; Kramer F; Stek A; Operskalski E; Kovacs A
Clin Infect Dis; 2012 Sep; 55(6):877-84. PubMed ID: 22675157
[TBL] [Abstract][Full Text] [Related]
60. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
Mandelbrot L; Landreau-Mascaro A; Rekacewicz C; Berrebi A; Bénifla JL; Burgard M; Lachassine E; Barret B; Chaix ML; Bongain A; Ciraru-Vigneron N; Crenn-Hébert C; Delfraissy JF; Rouzioux C; Mayaux MJ; Blanche S;
JAMA; 2001 Apr; 285(16):2083-93. PubMed ID: 11311097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
